SCYNEXIS
SCYX
#10654
Rank
S$31.56 M
Marketcap
S$3.17
Share price
-5.62%
Change (1 day)
311.61%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): S-$6.67

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is S-$6.71. In 2025 the company made an earnings per share (EPS) of S-$1.75 an increase over its 2024 EPS that were of S-$4.54.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$6.67279.91%
2025S-$1.75-61.36%
2024S-$4.54-131.43%
2023S$14.45-195.24%
2022S-$15.1717.6%
2021S-$12.90-75.73%
2020S-$53.15-46.24%
2019S-$98.87242.14%
2018S-$28.90-70.21%
2017S-$97.01-40.51%
2016S-$163.06-41.04%
2015S-$276.58157.69%
2014S-$107.33-96.49%
2013S-$3,055307.85%
2012S-$749.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
S-$16.62 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
S$2.33-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
S-$8.17 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
S-$1.28-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA